ERIC PCR-Based Genotyping and Antimicrobial Susceptibility of Brucella melitensis Isolates Recovered from Slaughtered Camels in Egypt

Document Type : Original Article

Authors

1 Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt

2 Professor of Microbiology, Faculty of Veterinary Medicine, Cairo University

3 Brucellosis Research Department, Agricultural Research Center, Animal Health Research Institute, P.O. Box 264-Giza, Cairo 12618, Egypt

4 Department of Zoonoses, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt

5 Department of Brucellosis Research, Animal Health Research Institute, Dokki, Giza, Egypt

6 Department of Brucellosis Research, Agricultural Research Center, Animal Health Research Institute, P.O. Box 264‑Giza, Cairo 12618, Egypt.

Abstract

Brucellosis 
is a zoonotic disease affecting various animals, including camels. Our study aimed to isolate, identify, genotype the Brucella species circulating in camels and to test the antibiotic susceptibility of the Brucella isolates against 8 antibacterial agents commonly prescribed for human brucellosis. Lymph nodes (n = 350) were collected from camels from different Egyptian governorates. As identified by bacteriological and Abortus meltensis ovis suis PCR, 14 Brucella isolates recovered from 350 lymph nodes were identified as B. melitensis biovar 3 (4%). The results of antimicrobial susceptibility assays denoted that all B. melitensis strains tested in this study were susceptible to ciprofloxacin, tigecycline, gentamicin and rifampin whereas 28.6%, 28.6%, 21.4% and 7.1% of the isolates were resistant to doxycycline, tetracycline, trimethoprim-sulfamethoxazole and erythromycin, respectively Meanwhile, 21.4% and 7.1% of the isolates were resistant to trimethoprim-sulfamethoxazole and erythromycin, respectively. The genetic analyses based on ERIC-PCR indicated that B. melitensis isolates of the current study are almost identical to Brucella strains recovered from goats raised away from the study area. In conclusion, The emergence of resistance to the first and second lines of therapeutics prescribed for brucellosis limits the drug choices. Therefore, we strongly advise performing routine antibiotic sensitivity testing and updating zone diameter breakpoints for those drugs prescribed for treatment of human brucellosis. ERIC-PCR is a comparatively swift and affordable method for determining the genetic fingerprinting of Brucella species in developing countries that cannot finance sequence-based fingerprinting techniques. Our findings highlight the role of the mixed species husbandry system in brucella transmission between camels and other livestock.

Keywords

Main Subjects



Articles in Press, Corrected Proof
Available Online from 24 November 2024
  • Receive Date: 27 August 2024
  • Revise Date: 21 October 2024
  • Accept Date: 22 November 2024